Impact of treatment heterogeneity on drug resistance and supply chain costs

Eirini Spiliotopoulou, Maciej F. Boni, Prashant Yadav

Research output: Contribution to JournalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)158-171
JournalSocio-Economic Planning Sciences
Issue number3
Publication statusPublished - Sep 2013
Externally publishedYes


  • Treatment heterogeneity
  • Drug resistance
  • Drug assortment
  • Costs of variety
  • Healthcare supply chains

VU Research Profile

  • Human Health and Life Sciences

Cite this